Unlike the other posts on this board that seem unhealthily obsessed with the ceo of this outfit, I've been researching the product Contego.
First there is no data from this company on Contego. Rather it seems that the new board members are the worlds experts on the therapy. When I looked at each of their Bios I see that they are working in the BEST cancer hospitals and have the most prestigious pedigrees.
I am shocked that the Genesis website does not have any information on the origin of Contego! The therapy was invented at the National Cancer Institute in Bethesda Maryland and is still the best therapy for Metastatic Melanoma available. It is actually call Til Therapy in the cancer world. that stands for Tumor Infiltrating Lymphocytes. It is very similar to Provenge from Dendreon.
Once I knew that Contego was just rebranding of Til, it was easy to find out about this product. These are clinical trials being run using Til/Contego currently, they are all
What is interesting is that I was reading bulletin boards where melanoma patients discuss what therapy the are on, and they have a good impression of Til. What is strange is that there have already been Phase II clinical trials that have shown that this therapy works better the standard treatment which is high dose IL-2 (HD IL-2). So the question I have is " what does this company contribute to the equation?"
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.